Claudia Riedel
Bonn, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive Analysis.
Journal: Pharmaceutical medicine
Published: June 18, 2026
Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts - a multi-stakeholder consensus view for a practical approach in Germany.
Journal: Frontiers in pharmacology
Published: September 05, 2025
Main characteristics of the new authorisation procedure for clinical trials with medicinal products according to regulation (EU) no 536/2014 and the cooperation between the member states
Journal: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
Published: August 05, 2022
A Study of Regulatory Challenges of Pediatric Oncology Phase I/II Trial Submissions and Guidance on Protocol Development.
Journal: Clinical pharmacology and therapeutics
Published: March 30, 2021
Master protocols in clinical trials: a universal Swiss Army knife?
Journal: The Lancet. Oncology
Published: January 16, 2019
Principles of the EU Clinical Trials Regulation No 536/2014 : What will change?
Journal: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
Published: July 08, 2017
Improving drug licensing for children and adolescents : Position paper from the More Medicines for Minors Symposion 8 June 2015 in Bonn
Journal: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
Published: October 26, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026